Literature DB >> 2047941

Molecular characterization of PKU allele prevalent in southern Europe and Ireland.

M Dasovich1, D Konecki, U Lichter-Konecki, R C Eisensmith, F Güttler, E Naughton, C Mullins, M Giovannini, E Riva, S L Woo.   

Abstract

A novel substitution has been characterized in the phenylalanine hydroxylase (PAH) gene that is linked exclusively to mutant haplotype 6, which is prevalent in southern Europe but rare in northern and eastern Europe. It is a G-to-A transition in intron 10, 11 bases from exon 11. This substitution creates an additional AG dinucleotide, which may serve as a cryptic splice acceptor site. Individuals who bear this substitution in the homozygous state have a severe PKU phenotype with pretreatment serum phenylalanine levels over 1200 mumol/liter. The frequency and distribution of this substitution among European populations suggests two possible founding populations, one being Middle Eastern and the other Roman. The use of this substitution as a marker to identify PKU chromosomes will be an invaluable aid to carrier screening and prenatal diagnosis in populations where mutant haplotype 6 is prevalent.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2047941     DOI: 10.1007/bf01232824

Source DB:  PubMed          Journal:  Somat Cell Mol Genet        ISSN: 0740-7750


  14 in total

1.  Phenylketonuria in Italy: distinct distribution pattern of three mutations of the phenylalanine hydroxylase gene.

Authors:  V Guzzetta; G Bonapace; I Dianzani; G Parenti; M Lecora; S Giannattasio; D Concolino; P Strisciuglio; G Sebastio; G Andria
Journal:  J Inherit Metab Dis       Date:  1997-09       Impact factor: 4.982

2.  Population genetics of hyperphenylalaninaemia resulting from phenylalanine hydroxylase deficiency in Portugal.

Authors:  I Rivera; P Leandro; U Lichter-Konecki; I Tavares de Almeida; M C Lechner
Journal:  J Med Genet       Date:  1998-04       Impact factor: 6.318

3.  Different phenotypic manifestations associated with identical phenylketonuria genotypes in two Spanish families.

Authors:  B Pérez; L R Desviat; M J García; M Ugarte
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

4.  Heterogeneity of phenylketonuria in Belgium at the genotype-phenotype level.

Authors:  B Francois; C Vandevyver; P Verelst; L Phillippaert; J Raus
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

5.  Phenylketonuria in Spain: RFLP haplotypes and linked mutations.

Authors:  L R Desviat; B Pérez; M Ugarte
Journal:  Hum Genet       Date:  1993-10-01       Impact factor: 4.132

6.  Associations between mutations and a VNTR in the human phenylalanine hydroxylase gene.

Authors:  A A Goltsov; R C Eisensmith; D S Konecki; U Lichter-Konecki; S L Woo
Journal:  Am J Hum Genet       Date:  1992-09       Impact factor: 11.025

7.  Haplotype distribution and mutations at the PAH locus in Croatia.

Authors:  I Barić; D Mardesić; G Gjurić; V Sarnavka; B Göbel-Schreiner; U Lichter-Konecki; D S Konecki; F K Trefz
Journal:  Hum Genet       Date:  1992 Sep-Oct       Impact factor: 4.132

8.  Phenylalanine hydroxylase genotypes, predicted residual enzyme activity and phenotypic parameters of diagnosis and treatment of phenylketonuria.

Authors:  P Burgard; A Rupp; D S Konecki; F K Trefz; H Schmidt; U Lichter-Konecki
Journal:  Eur J Pediatr       Date:  1996-07       Impact factor: 3.183

9.  Molecular analysis of contiguous exons of the phenylalanine hydroxylase gene: identification of a new PKU mutation.

Authors:  I Dianzani; C Camaschella; G Saglio; G B Ferrero; S Ramus; A Ponzone; R G Cotton
Journal:  J Med Genet       Date:  1993-03       Impact factor: 6.318

10.  Relation between genotype and phenotype in Swedish phenylketonuria and hyperphenylalaninemia patients.

Authors:  E Svensson; U von Döbeln; R C Eisensmith; L Hagenfeldt; S L Woo
Journal:  Eur J Pediatr       Date:  1993-02       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.